This inventor holds 1 USPTO granted patent and 5 published patent applications and 1 EPO patent. Top assignee: Hoffmann-La Roche Inc.. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Katharina Lechner - Innovator in Combination Therapies
Introduction
Katharina Lechner is a notable inventor based in Muenchen, Germany. She is currently associated with F. Hoffmann-La Roche AG, a leading healthcare company. Although she has not yet been granted any patents, her work focuses on innovative therapies that address significant medical challenges.
Latest Patent Applications
Katharina Lechner has filed several patent applications that showcase her contributions to the field of medicine. One of her latest applications is titled "Dosing for Combination Treatment with Anti-CD20/Anti-CD3 Bispecific Antibody and Anti-CD79B Antibody Drug Conjugate." This invention pertains to the treatment of subjects with CD20-positive cell proliferative disorders, such as non-Hodgkin's lymphomas. It involves administering a combination of an anti-CD20/anti-CD3 bispecific antibody and an anti-CD79b antibody drug conjugate. Another significant application is "Combination Therapy with Coagulation Factors and Multispecific Antibodies," which relates to therapies for patients with bleeding disorders. This invention comprises the application of specific blood coagulation factors in combination with antibodies.
Conclusion
Katharina Lechner is making strides in the field of medical innovation through her patent applications focused on combination therapies. Her work has the potential to significantly impact the treatment of various disorders.